Curriculum vitae for mark cushman - Purdue College of Pharmacy ...

Mark Cushman
303. J.-H. Liang, W. Lv, X.-L. Li, K. An; M. Cushman, H. Wang, and Y.-C. Xu, " Synthesis
and Antibacterial Activity of 9-Oxime Ether Non-ketolides, and Novel Binding Mode of
Alkylides with Bacterial rRNA," Bioorg. Med. Chem. Lett. 23, 1387–1393 (2013).
Intellectual Property Disclosures (since 2007):
1. "Anti-trypanosomal activity of topoisomerase IB-targeting indenoisoquinolines", Mark S.
Cushman, Andrew Morrell, Dongpei Sang, Rahul Bakshi, and Theresa Shapiro, June 12,
2007.
2. "Hydrolytically Stable Alkenyldiarylmethane Non-nucleoside Reverse Transcriptase
Inhibitors," Mark S. Cushman and Matthew Cullen, March 1, 2007.
3. "14-Substituted Aromathecin Topoisomerase I Inhibitors," Mark S. Cushman, Maris
Cinelli, Andrew Morrell, and Yves Pommier, April 17, 2008.
4. "Riboflavin Synthase Inhibitors as Potential Antitubercular Agents," Mark S. Cushman,
Yanlei Zhang, Markus Fischer, and Adelbert Bacher, April 8, 2009.
5. "Discovery of a Novel Indenoisoquinoline Inducer of the Retinoid X Receptor Response
Element (RXRE)," Mark S. Cushman, John M. Pezzuto, Eun-Jung Park, and Andrew
Morrell, June 2, 2009.
6. "Casimiroin-Based Aromatase and QR2 Inhibitors," Mark S. Cushman, John M. Pezzuto,
and Arup Maiti, January 21, 2009.
7. "New Antitumor Norindenoisoquinoline Topoisomerase I Inhibitors," Mark S. Cushman,
Yunlong Song, and Yves Pommier, August 11, 2009.
8. "Substituted Dibenzo[c,h]naphthyridinediones, 11-Chlorodibenzo[c,h]naphthyridinones
and Dibenzo[c,h]naphthyridines as Topoisomerase I Inhibitors and Potential Anticancer
Agents," Mark S. Cushman, Evgeny Kiselev, and Yves Pommier, June 10, 2010.
9. "Indenoisoquinoline Topoisomerase I Inhibitors Substituted with Carbohydrates," Mark
S. Cushman, Katherine Peterson, Maris Cinelli, Andrew Morrell, and Yves Pommier,
October 22, 2010.
10. " Potential Chemopreventive Agents Based on the Structure of the Lead Compound
2-Bromo-1-hydroxyphenazine, Isolated from Streptomyces sp., Strain CNS284," Mark S.
Cushman and Martin Conda-Sheridan, November 1, 2010.
11. "Preparation of Phenylthiazole Derivatives as Antiviral Agents," Abdelrahman Salah
Mayhoub, Mansoora Khaliq, Richard Kuhn, and Mark S. Cushman, February 4, 2011.
12. "Preparation of Azole Derivatives as Cancer Chemopreventive Agents," Abdelrahman
Salah Mayhoub, John M. Pezzuto, and Mark S. Cushman, April 1, 2011.
13. "Synthesis and Use of Dual Tyrosyl-DNA Phosphodiesterase I (Tdp1)-Topoisomerase I
(Top1) Inhibitors", Mark S. Cushman and Nguyen Trung, March 8, 2012.
14. "Dibenzo[c,h][1,5]naphthyridinediones as Topoisomerase I Inhibitors: Design, Synthesis,
and Biological Evaluation," Mark S. Cushman and Evgeny Kiselev, March 21, 2012.
15. "A Novel Synthesis of the Anticancer Drugs Indotecan (LMP400) and Indotecan
(LMP776)," Mark S. Cushman, June 6, 2012.
16. "Antimicrobial activity of novel substituted thiazoles against methicillin-resistant
Staphylococcus aureus (MRSA)", Mark S. Cushman, Abdelrahman S. Mayhoub, and
Seleem N. Mohamed, September 25, 2012.
17. "Indenoisoquinoline Rexinoids with Chemopreventive Potential," Mark S. Cushman,
Martin Conda-Sheridan, and John M. Pezzuto, January 7, 2013.
22